Selecta Biosciences
SELB
#8432
Rank
NZ$0.22 B
Marketcap
$1.48
Share price
-8.00%
Change (1 day)
-38.33%
Change (1 year)

Revenue for Selecta Biosciences (SELB)

Revenue in 2023 (TTM): NZ$55.5 Million

According to Selecta Biosciences's latest financial reports the company's current revenue (TTM ) is NZ$57.84 Million. In 2022 the company made a revenue of NZ$0.17 Billion an increase over the revenue in the year 2021 that were of NZ$0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Selecta Biosciences from 2015 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) NZ$55.5 M-68.19%
2022 NZ$0.17 B40.08%
2021 NZ$0.12 B441.5%
2020 NZ$23 M132.01%
2019 NZ$9.91 M636.45%
2018 NZ$1.34 M361.88%
2017 NZ$0.29 M-97.5%
2016 NZ$11.66 M32.86%
2015 NZ$8.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA